Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
Fiction
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts125/v4/06/5a/df/065adfee-a7f1-da25-7540-a2646eda9449/mza_16158925352961033298.jpg/600x600bb.jpg
Frazis Capital Podcast
Michael Frazis
113 episodes
3 days ago
Michael Frazis, Misha Saul and guests discuss the life sciences, technology, and their latest investment ideas.
Show more...
Investing
Business
RSS
All content for Frazis Capital Podcast is the property of Michael Frazis and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Michael Frazis, Misha Saul and guests discuss the life sciences, technology, and their latest investment ideas.
Show more...
Investing
Business
https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded_nologo/1387964/1387964-1621055592219-d04d336721727.jpg
#82: A fresh look at true customer love and explosive growth, HIMS, Clarity Pharma and semis
Frazis Capital Podcast
35 minutes 41 seconds
8 months ago
#82: A fresh look at true customer love and explosive growth, HIMS, Clarity Pharma and semis

00:0 True Customer Love and Explosive Growth02:05 - Portfolio update04:09 - Hims: A Case Study in True Customer Love and Explosive Growth07:18 - Defining True Customer Love11:33 - The Future of Hims and Market Dynamics in GLP-1sClarity's Fast-Tracked Approval and Market Response27:06 - Short Selling in CU629:59 - If you want to be valued like a US biotech company, you have to be capitalized like one32:10 - Clarity's FDA trial timeline36:33 - Updates from Nubank and MercadoLibre 40:54 - Customer Love and Explosive Growth44:45 - Identifying Explosive Growth Opportunities52:02 - Influence of Tech Leaders on Market Trends59:30 - Long-Term Perspectives on Semiconductor Growth

Frazis Capital Podcast
Michael Frazis, Misha Saul and guests discuss the life sciences, technology, and their latest investment ideas.